diagnosing and monitoring ventilator- associated...

22
Diagnosing and monitoring ventilator- associated pneumonia BSAC spring meeting 23/3/2010 Mihye Lee Microbiology StR Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust [email protected] Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Upload: vuliem

Post on 14-May-2019

220 views

Category:

Documents


0 download

TRANSCRIPT

Diagnosing and monitoring ventilator-associated pneumonia

BSAC spring meeting 23/3/2010

Mihye Lee Microbiology StR

Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

[email protected]

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Introduction

•  Saving Lives. DoH High impact intervention No.5 : Care bundle for ventilated patients Care bundle compliance reported to IPC

•  Does good care bundle compliance translate into good outcomes?

A way to measure outcome Discussion of VAP pathway

Commissioners attempting to use VAP rate as a quality performance indicator

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Controversies

•  Controversies with definition and diagnosis of VAP

•  Non-controversial: VAP increases mortality and length of stay

“The definition of VAP is perhaps the most subjective of the common device-related healthcare-associated

infection” The society for healthcare epidemiology of America (SHEA) and infectious diseases society of America

(IDSA), 2008

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Definitions American Thoracic Society (ATS)+IDSA, 2005:

“ VAP refers to pneumonia that arises more than 48–72 hours after endotracheal intubation.”

National Institute for Health and Clinical Excellence (NICE), 2008 : “There is no generally accepted definition of VAP in mechanically ventilated patients, but it is often defined as pneumonia that develops 48hours or more after intubation with an endotracheal or tracheostomy tube and that was, not present before intubation”

Centers for Disease Control and Prevention (CDC) : “Pneumonia that occurs in a patient who was intubated and ventilated at the time of or within 48 hours before the onset of the pneumonia.”

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Diagnostic criteria •  VAP has been diagnosed by the clinical criteria

published by Johanson et al. 1972

•  Sensitivity 69%a, Specificity 75%a aAlvaro Rea-Neto et al, Critical Care 2008

Presence of new or persistent infiltrates on CXR and any 2 of: - Febrile > 38.3 -leukocytosis or leucopenia (>11 or < 3.5) -Purulent tracheobronchial secretions

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Diagnostic criteria VAP can be accurately diagnosed by any one of several standard criteriab: •  histopathologic examination of lung tissue either on lung biopsy or at

autopsy •  rapid cavitation of a pulmonary infiltrate in the absence of cancer or

tuberculosis on CT •  positive pleural fluid culture •  same species with same antibiogram isolated from blood and respiratory

secretions without another identifiable source of bacteremia

bC. Glen Mayhall, Emerging Infectious Diseases, 2001

Invasive procedures Uncommon manifestations or complications of VAP Different approach is needed for the definitive diagnosis of VAP

C. Glen Mayhall, Emerging Infectious Diseases, 2001

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Diagnostic criteria

•  Different strategies for diagnosing VAP •  Variable sensitivities and specificities •  Clinical : e.g. CPIS (sens: 72- 93%, spec: 42-85 %)

•  Semi-quantitative microbiology

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Diagnostic criteria

•  Different strategies for diagnosing VAP •  Variable sensitivities and specificities •  Clinical : e.g. CPIS (sens: 72- 93%, spec: 42-85 %)

•  Semi-quantitative microbiology

Torres, 2000 BAL (104): sens=83%, spec=68% PSB(103): sens=67%, spec=75%

Fabregas, 1999 TBA(105): sens=69%, spec=92% BAL(104): sens=77%, spec=58%

Papazian, 1995 BAL(104): sens=58%, spec=95% PSB(103): sens=42%, spec=95%

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Diagnostic criteria

•  Different strategies for diagnosing VAP •  Variable sensitivities and specificities •  Clinical : e.g. CPIS (sens: 72- 93%, spec: 42-85 %)

•  Semi-quantitative microbiology

Modified CPIS > 6, positive semi-quantitative microbiology and MDT

VAP forum

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Diagnostic criteria

•  Different strategies for diagnosing VAP

•  Variable sensitivities and specificities

•  Clinical : e.g. CPIS (sens: 72- 93%, spec: 42-85 %)

•  Semi-quantitative microbiology

Modified CPIS > 6, positive semi-quantitative microbiology and MDT

VAP forum

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Methods

•  Audit period: 116 days from 2009 to 2010 •  Data collection: ventilated for > 48hrs + clinical

deterioration suspected to be due to respiratory infection were included in proforma

•  Multidisciplinary team (MDT) VAP forum: attended by Microbiologists and Intensivists to discuss and finalise VAP cases

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Front page local VAP pathway database

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Page 2&3 of VAP pathway database

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Last page of VAP pathway database Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Electronic VAP pathway database

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Results

•  12 episodes were collected on proforma

•  2 long stay patients included twice suspected episodes at two different points during the stay

•  MDT VAP forum

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Results 12 episodes 3 VAPs

5 failure to meet

diagnostic criteria for VAP

2 CPIS <6

2 Ventilated < 48°

1 No positive

micro culture

1 CAP

1 Post-op complication

1 TAP

1 Pos micro prior to

intubation

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Results

•  Denominator data over 116 days:-

No. patients admitted : 366 patients No. patient ventilated : 199 patients (54%) No. of total ventilated days : 759 days

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Results

•  No. of patients diagnosed with VAP: 3 patients 4 in 1000 ventilated days

•  One patient diagnosed with TAP (tube-associated pneumonia)

•  Pilot audit over 61 days:- 12 in 1000 ventilated days

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Conclusions

•  Developed Comprehensive process to diagnose VAP

•  Implemented an agreed pathway in order to monitor VAP rate

•  Audit outcome from stepwise changes in the care bundle ongoing measure of quality of care

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Continued controversies

•  Monitoring other healthcare-associated pneumonia that do not fit the VAP definition? eg. TAP

•  Necessity to establish national standards to diagnose and monitor VAPs?

•  Should VAP be a quality performance indicator for critical care?

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010

Acknowledgements

S Wyllie : Microbiology consultant M Williams : Critical Care consultant S Mathieu, C Allan, J Coakes : Critical care SpR

Dr. Mihye Lee, Portsmouth Hospital. BSAC 2010